Literature DB >> 11719051

Rho family proteins: coordinating cell responses.

A J Ridley1.   

Abstract

Rho GTPases hit the headlines several times in 1990-1992: the proteins regulating their GTP-GDP cycle were identified and they were found to be key signal transducers, mediating growth factor-induced changes to the actin cytoskeleton and activating the phagocyte NADPH oxidase. Since then, they have been implicated in numerous cellular processes, from cell migration to cell survival, transcriptional regulation and vesicle trafficking. An explanation for why they affect so many aspects of cell behavior might lie in their ability to interact with a number of downstream targets, so that they can coordinately activate several molecular processes required for a particular cellular response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11719051     DOI: 10.1016/s0962-8924(01)02153-5

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  213 in total

Review 1.  The cadherin-catenin adhesion system in signaling and cancer.

Authors:  Maralice Conacci-Sorrell; Jacob Zhurinsky; Avri Ben-Ze'ev
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

2.  Molecular recognition of leucine-aspartate repeat (LD) motifs by the focal adhesion targeting homology domain of cerebral cavernous malformation 3 (CCM3).

Authors:  Xiaofeng Li; Weidong Ji; Rong Zhang; Ewa Folta-Stogniew; Wang Min; Titus J Boggon
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

3.  Coactivation of Rac1 and Cdc42 at lamellipodia and membrane ruffles induced by epidermal growth factor.

Authors:  Kazuo Kurokawa; Reina E Itoh; Hisayoshi Yoshizaki; Yusuke Ohba Takeshi Nakamura; Michiyuki Matsuda
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

Review 4.  Statins and the role of nitric oxide in chronic heart failure.

Authors:  Stephan von Haehling; Stefan D Anker; Eberhard Bassenge
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

Review 5.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

6.  Regulation of TLR4-mediated signaling by IBP/Def6, a novel activator of Rho GTPases.

Authors:  Qinzhong Chen; Sanjay Gupta; Alessandra B Pernis
Journal:  J Leukoc Biol       Date:  2008-12-12       Impact factor: 4.962

7.  Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors.

Authors:  Xun Shang; Fillipo Marchioni; Chris R Evelyn; Nisha Sipes; Xuan Zhou; William Seibel; Matthew Wortman; Yi Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

8.  GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins.

Authors:  Chunzhi Xia; Wenbin Ma; Lewis Joe Stafford; Chengyu Liu; Liming Gong; James F Martin; Mingyao Liu
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  Alpha4beta1 integrin/ligand interaction inhibits alpha5beta1-induced stress fibers and focal adhesions via down-regulation of RhoA and induces melanoma cell migration.

Authors:  Jose V Moyano; Alfredo Maqueda; Benito Casanova; Angeles Garcia-Pardo
Journal:  Mol Biol Cell       Date:  2003-05-18       Impact factor: 4.138

10.  Inhibition of farnesyl pyrophosphate synthase prevents angiotensin II-induced cardiac fibrosis in vitro.

Authors:  Z Li; X Bi; M Wang; J Zhang; J Song; X Shen; J Han; G Fu; Y Ye
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.